Vivos Therapeutics, Inc. Financing Cash Flow
Vivos Therapeutics, Inc. (VVOS) reported Financing Cash Flow of $9.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.23M.
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $6.11M.
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $4.33M, a 41.94% increase year-over-year.
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $2.76M, a 27.04% decline year-over-year.
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $18.56M, a 3.82% increase from fiscal 2024.
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $17.88M, a 63.65% increase from fiscal 2023.
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $10.92M.
- Vivos Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $24.17M, a 2.68% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $9.34M 10-Q · filed 2026-08-14 | $13.67M derived: sum of 3 quarters · filed 2026-08-14 | $16.43M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $6.11M 10-Q · filed 2026-05-20 | $10.44M derived: sum of 2 quarters · filed 2026-05-20 | $13.21M derived: sum of 3 quarters · filed 2026-05-20 | ||||
| 2025-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $7.10M derived: sum of 2 quarters · filed 2026-04-15 | $18.56M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $14.22M 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | $11.46M 10-Q · filed 2026-08-14 | ||||||
| 2024-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $6.84M derived: sum of 2 quarters · filed 2026-04-15 | $14.24M derived: sum of 3 quarters · filed 2026-04-15 | $17.88M 10-K · filed 2026-04-15 | |||
| 2024-09-30 | $3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $11.19M derived: sum of 2 quarters · filed 2025-11-19 | $14.82M 10-Q · filed 2025-11-19 | $18.39M derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $11.04M 10-Q · filed 2025-08-19 | $14.60M derived: sum of 3 quarters · filed 2025-08-19 | $14.60M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2024-03-31 | $3.63M 10-Q · filed 2025-05-15 | $7.20M derived: sum of 2 quarters · filed 2025-05-15 | $7.20M derived: sum of 3 quarters · filed 2025-05-15 | $7.20M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.57M derived: sum of 2 quarters · filed 2025-03-31 | $3.57M derived: sum of 3 quarters · filed 2025-03-31 | $10.92M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $7.36M 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.36M 10-Q · filed 2024-08-14 | |||||
| 2023-03-31 | $7.36M 10-Q · filed 2024-05-14 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.17M derived: sum of 2 quarters · filed 2023-03-30 | $24.19M derived: sum of 3 quarters · filed 2023-03-30 | $24.17M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $24.19M derived: sum of 2 quarters · filed 2022-12-20 | $24.17M 10-Q · filed 2022-12-20 | $24.17M 10-Q · filed 2021-11-15 | $44.54M derived: sum of 4 quarters · filed 2022-12-20 | ||
| 2021-06-30 | $25.37M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | $25.34M 10-Q · filed 2022-12-20 | $25.34M 10-Q · filed 2021-08-12 | $45.71M derived: sum of 3 quarters · filed 2022-12-20 | $47.53M derived: sum of 4 quarters · filed 2022-12-20 | ||
| 2021-03-31 | -$25.00K 10-Q/A · filed 2022-11-25 | $20.34M derived: sum of 2 quarters · filed 2022-11-25 | $22.17M derived: sum of 3 quarters · filed 2022-11-25 | $23.43M derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | $20.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $22.19M derived: sum of 2 quarters · filed 2022-03-31 | $23.46M derived: sum of 3 quarters · filed 2022-03-31 | $23.54M 10-K · filed 2022-03-31 | $23.54M 10-K · filed 2021-03-25 | ||
| 2020-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.09M derived: sum of 2 quarters · filed 2021-11-15 | $3.17M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.34M 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $79.52K 10-Q · filed 2021-05-17 | ||||||
| 2019-12-31 | $4.47M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |